Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +2.97% | +6.12% | +11.83% |
Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Chart calendar Pulmatrix, Inc.
Upcoming events on Pulmatrix, Inc.
Past events on Pulmatrix, Inc.
2024-03-28 09:05 am | Q4 2023 Earnings Release |
2023-11-09 09:05 am | Q3 2023 Earnings Release |
2023-08-10 09:05 am | Q2 2023 Earnings Release |
2023-06-16 01:35 pm | American Headache Society Scientific Meeting |
2023-06-05 12:45 pm | BIO International Convention |
2023-05-12 09:05 am | Q1 2023 Earnings Release |
2023-03-30 09:05 am | Q4 2022 Earnings Release |
2023-02-24 04:15 pm | American Academy of Allergy, Asthma & Immunology Meeting - Poster #56 |
2023-02-03 10:00 am | Investor Meeting - Key Opinion Leader |
2022-11-10 09:05 am | Q3 2022 Earnings Release |
2022-08-08 09:05 am | Interim 2022 Earnings Release |
2022-05-12 09:05 am | Q1 2022 Earnings Release |
2022-03-29 09:05 am | FY 2021 Earnings Release |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-11-10 04:15 pm | Q3 2021 Earnings Release |
2021-08-10 09:10 am | Interim 2021 Earnings Release |
2021-04-30 04:35 pm | Q1 2021 Earnings Release |
2021-04-23 10:00 am | Investor Meeting - Key Opinion Leader |
2021-03-23 09:05 am | FY 2020 Earnings Release |
2021-01-05 | LifeSci Advisors Corporate Access Event |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,91 6,23 27.07% | 12,6 10,6 18.81% | 5,17 5,89 -12.23% | 6,07 6,24 -2.63% |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -13,4 -14,7 8.49% | -9,86 -13,9 29.23% | -16,6 -20,7 19.95% | -18,9 -19,8 4.27% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -15,0 -37.15% | -19,3 -23,1 16.57% | -20,2 -20,7 2.7% | -18,8 -19,7 4.33% |
Net income Million USD | Released Forecast Spread | -20,6 -15,0 -37.15% | -19,3 -23,1 16.57% | -23,4 -20,7 -12.73% | -18,8 -19,7 4.33% |
EPS USD | Released Forecast Spread | -24,6 -17,8 -38.2% | -13,4 -16,4 18.29% | -8,63 -7,80 -10.64% | -5,46 -5,76 5.21% |
Announcement Date | 26/03/20 | 23/03/21 | 29/03/22 | 30/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,46 1,18 -61.22% | 1,16 1,07 8.51% | 1,33 1,16 14.74% | 1,87 1,16 61.38% | 1,71 1,87 -8.76% | 1,84 1,51 21.8% | 1,75 1,86 -5.85% |
EBIT Million USD | Released Forecast Spread | -4,04 -4,60 12.11% | -4,96 -4,67 -6.27% | -4,56 -5,02 9.26% | -5,10 -5,09 -0.28% | -4,33 -5,17 16.34% | -3,99 -4,63 13.82% | -3,94 -4,03 2.28% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,03 -4,59 12.18% | -4,97 -4,67 -6.53% | -4,60 -5,02 8.52% | -5,05 -5,09 0.65% | -4,22 -5,07 16.81% | -3,82 -4,49 15.05% | -3,77 -3,85 2.08% |
Net income Million USD | Released Forecast Spread | -7,23 -4,59 -57.47% | -4,97 -4,67 -6.53% | -4,60 -5,02 8.52% | -5,05 -5,09 0.65% | -4,22 -5,07 16.81% | -3,82 -4,49 15.05% | -3,77 -3,85 2.08% |
EPS USD | Released Forecast Spread | -2,43 -1,60 -51.88% | -1,51 -1,41 -7.09% | -1,36 -1,51 9.93% | -1,45 -1,51 3.97% | -1,14 -1,44 20.83% | -1,04 -1,23 15.45% | -1,03 -1,05 1.9% |
Announcement Date | 29/03/22 | 12/05/22 | 10/08/22 | 10/11/22 | 30/03/23 | 10/08/23 | 09/11/23 |
Past sector events for Pulmatrix, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PULM Stock
- Calendar Pulmatrix, Inc.